Pulse Biosciences Net Income
| PLSE Stock | USD 13.99 0.37 2.72% |
As of the 30th of January, Pulse Biosciences holds the Variance of 8.12, coefficient of variation of (733.32), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulse Biosciences, as well as the relationship between them. Please check Pulse Biosciences information ratio and potential upside to decide if Pulse Biosciences is priced some-what accurately, providing market reflects its current price of 13.99 per share. Given that Pulse Biosciences has information ratio of (0.16), we recommend you to check out Pulse Biosciences's recent market performance to make sure the company can sustain itself at a future point.
Pulse Biosciences Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 9.7 K | Revenue | Earnings Share (1.14) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -48.2 M | -50.6 M | |
| Net Loss | -57.3 M | -54.4 M | |
| Net Loss | -48.2 M | -50.6 M | |
| Net Loss | (1.06) | (1.11) | |
| Net Income Per E B T | 0.90 | 0.70 |
Pulse | Net Income | Build AI portfolio with Pulse Stock |
Analyzing Pulse Biosciences's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Pulse Biosciences's current valuation and future prospects.
Latest Pulse Biosciences' Net Income Growth Pattern
Below is the plot of the Net Income of Pulse Biosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pulse Biosciences financial statement analysis. It represents the amount of money remaining after all of Pulse Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pulse Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulse Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (53.59 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Pulse Net Income Regression Statistics
| Arithmetic Mean | (28,841,935) | |
| Coefficient Of Variation | (85.01) | |
| Mean Deviation | 22,407,637 | |
| Median | (37,545,000) | |
| Standard Deviation | 24,517,439 | |
| Sample Variance | 601.1T | |
| Range | 62.7M | |
| R-Value | (0.90) | |
| Mean Square Error | 124.2T | |
| R-Squared | 0.81 | |
| Slope | (4,359,607) | |
| Total Sum of Squares | 9617.7T |
Pulse Net Income History
Other Fundumenentals of Pulse Biosciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Pulse Biosciences Net Income component correlations
Pulse Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pulse Biosciences is extremely important. It helps to project a fair market value of Pulse Stock properly, considering its historical fundamentals such as Net Income. Since Pulse Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pulse Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pulse Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Pulse diversify its offerings? Factors like these will boost the valuation of Pulse Biosciences. Anticipated expansion of Pulse directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulse Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Pulse Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pulse Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pulse Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Pulse Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulse Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pulse Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.
Pulse Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pulse Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pulse Biosciences.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Pulse Biosciences on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Pulse Biosciences or generate 0.0% return on investment in Pulse Biosciences over 90 days. Pulse Biosciences is related to or competes with STAAR Surgical, LifeMD, Beta Bionics, Kestra Medical, Immatics, Opko Health, and Dianthus Therapeutics. Pulse Biosciences, Inc. operates as a novel bioelectric medicine company More
Pulse Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pulse Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pulse Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 14.41 | |||
| Value At Risk | (4.51) | |||
| Potential Upside | 3.83 |
Pulse Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulse Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pulse Biosciences' standard deviation. In reality, there are many statistical measures that can use Pulse Biosciences historical prices to predict the future Pulse Biosciences' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.31) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pulse Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pulse Biosciences January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 2.23 | |||
| Coefficient Of Variation | (733.32) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.12 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 14.41 | |||
| Value At Risk | (4.51) | |||
| Potential Upside | 3.83 | |||
| Skewness | 0.577 | |||
| Kurtosis | 0.7745 |
Pulse Biosciences Backtested Returns
Pulse Biosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0866, which implies the firm had a -0.0866 % return per unit of risk over the last 3 months. Pulse Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pulse Biosciences' Coefficient Of Variation of (733.32), variance of 8.12, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The company holds a Beta of 1.28, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pulse Biosciences will likely underperform. At this point, Pulse Biosciences has a negative expected return of -0.26%. Please make sure to check Pulse Biosciences' potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Pulse Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.11 |
Insignificant predictability
Pulse Biosciences has insignificant predictability. Overlapping area represents the amount of predictability between Pulse Biosciences time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pulse Biosciences price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Pulse Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pulse Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Pulse Biosciences reported net income of (53.59 Million). This is 115.7% lower than that of the Health Care Equipment & Supplies sector and 153.78% lower than that of the Health Care industry. The net income for all United States stocks is 109.38% higher than that of the company.
Pulse Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulse Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulse Biosciences could also be used in its relative valuation, which is a method of valuing Pulse Biosciences by comparing valuation metrics of similar companies.Pulse Biosciences is currently under evaluation in net income category among its peers.
Pulse Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pulse Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pulse Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Pulse Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Pulse Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pulse Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pulse Biosciences' value.| Shares | Ubs Group Ag | 2025-06-30 | 50.1 K | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 48.3 K | Nuveen, Llc | 2025-06-30 | 48.2 K | Bank Of New York Mellon Corp | 2025-06-30 | 40.3 K | Barclays Plc | 2025-06-30 | 34.6 K | Swiss National Bank | 2025-06-30 | 32.1 K | Xtx Topco Ltd | 2025-06-30 | 30.9 K | Tiaa Trust National Association | 2025-06-30 | 27.3 K | Rhumbline Advisers | 2025-06-30 | 27 K | Blackrock Inc | 2025-06-30 | 1.3 M | Vanguard Group Inc | 2025-06-30 | 1.2 M |
Pulse Fundamentals
| Return On Equity | -0.87 | ||||
| Return On Asset | -0.49 | ||||
| Operating Margin | (236.83) % | ||||
| Current Valuation | 834.32 M | ||||
| Shares Outstanding | 67.77 M | ||||
| Shares Owned By Insiders | 73.94 % | ||||
| Shares Owned By Institutions | 8.74 % | ||||
| Number Of Shares Shorted | 2.57 M | ||||
| Price To Earning | (22.54) X | ||||
| Price To Book | 9.94 X | ||||
| Price To Sales | 10,732 X | ||||
| Gross Profit | (193 K) | ||||
| EBITDA | (55.08 M) | ||||
| Net Income | (53.59 M) | ||||
| Cash And Equivalents | 14.8 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 8.9 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 3.14 X | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (36.34 M) | ||||
| Short Ratio | 14.95 X | ||||
| Earnings Per Share | (1.14) X | ||||
| Target Price | 22.0 | ||||
| Number Of Employees | 75 | ||||
| Beta | 1.79 | ||||
| Market Capitalization | 958.23 M | ||||
| Total Asset | 132.46 M | ||||
| Retained Earnings | (390.5 M) | ||||
| Working Capital | 109.39 M | ||||
| Current Asset | 4 M | ||||
| Current Liabilities | 660 K | ||||
| Net Asset | 132.46 M |
About Pulse Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pulse Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulse Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulse Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Check out For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Health Care Equipment & Supplies sector continue expanding? Could Pulse diversify its offerings? Factors like these will boost the valuation of Pulse Biosciences. Anticipated expansion of Pulse directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulse Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Pulse Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pulse Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pulse Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Pulse Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulse Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pulse Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.